|
|
|
|
LEADER |
03908nmm a2200349 u 4500 |
001 |
EB000667456 |
003 |
EBX01000000000000001349877 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
140122 ||| eng |
020 |
|
|
|a 9783642602580
|
100 |
1 |
|
|a Petrovich, Zbigniew
|e [editor]
|
245 |
0 |
0 |
|a Carcinoma of the Bladder
|h Elektronische Ressource
|b Innovations in Management
|c edited by Zbigniew Petrovich, Luc Baert, Luther W. Brady
|
250 |
|
|
|a 1st ed. 1998
|
260 |
|
|
|a Berlin, Heidelberg
|b Springer Berlin Heidelberg
|c 1998, 1998
|
300 |
|
|
|a XIII, 325 p
|b online resource
|
505 |
0 |
|
|a 1 Epidemiology of Bladder Cancer -- 2 Natural History of Bladder Carcinoma -- 3 Prognostic Factors in Bladder Cancer: Emphasis on Immunohistochemical Analysis -- 4 Molecular Genetics in Carcinoma of the Bladder -- 5 Pathology of Bladder Cancer -- 6 Imaging Modalities in the Diagnosis and Staging of Carcinoma of the Bladder -- 7 Contemporary Nonimaging Methods in the Diagnosis and Prognosis of Carcinoma of the Bladder -- 8 Staging of Bladder Cancer -- 9 Photodynamic Therapy of Bladder Cancer -- 10 Fluorescence Detection of Bladder Cancer -- 11 Treatment of Ta, T1 Bladder Tumors: Recent Results of the EORTC-GU Group -- 12 Surgical Treatment of Carcinoma of the Bladder: The USC Experience -- 13 Prophylactic Urethrectomy: When and How? -- 14 Orthotopic Reconstruction Following Radical Cystectomy: The USC Experience -- 15 Complications of Radical Cystectomy -- 16 Long-term Results of Brachytherapy with Iridium-192 Implants --
|
505 |
0 |
|
|a 26 Special Considerations in the Management of Carcinoma in the Neurogenic Bladder -- 27 Hyperthermia in Bladder Cancer -- 28 Management of Patients with Metastatic Carcinoma of the Blader -- 29 National Differences in the Management of Bladder Cancer -- List of Contributors
|
505 |
0 |
|
|a 17 Bladder-Conserving Therapy for Invasive Bladder Cancer Using Transurethral Surgery, Chemotherapy, and Radiation Therapy with Patient Selection by Initial Treatment Response -- 18 Muscle-Invasive Bladder Cancer: Transurethral Resection and Radiochemotherapy as an Organ-Sparing Treatment Option -- 19 External Radiotherapy in the Treatment of Muscle-Invasive Transitional Cell Carcinoma of the Bladder -- 20 Chemotherapy Before Definitive Treatment for Locally Advanced Bladder Cancer -- 21 Continuous Infusion Chemotherapy and Irradiation in the Treatment of Advanced Bladder Carcinoma -- 22 Postoperative Chemotherapy for Bladder Carcinoma -- 23 Management of Patients with Pelvic Recurrence Following Radical Cystectomy -- 24 Management of Patients with Failure Following Definitive Radiotherapy -- 25 Treatment-Related Complications for Bladder Carcinoma: Radical Surgery Versus Bladder-Preserving Techniques --
|
653 |
|
|
|a Radiology
|
653 |
|
|
|a Urology
|
653 |
|
|
|a Oncology
|
653 |
|
|
|a Pathology
|
700 |
1 |
|
|a Baert, Luc
|e [editor]
|
700 |
1 |
|
|a Brady, Luther W.
|e [editor]
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
490 |
0 |
|
|a Radiation Oncology
|
028 |
5 |
0 |
|a 10.1007/978-3-642-60258-0
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-642-60258-0?nosfx=y
|x Verlag
|3 Volltext
|
082 |
0 |
|
|a 616.0757
|
520 |
|
|
|a This volume provides up-to-date information on the diagnosis and treatment of carcinoma of the bladder and will appeal to all physicians concerned with this field. Advances in molecular genetics that are of importance to clinical practice are discussed in depth. Progress in both imaging and nonimaging modalities is well documented and critically evaluated in a manner that will prove invaluable for practicing uro-oncologists. Furthermore, the management of patients with superficial, muscle-invasive, and advanced disease is discussed, and new treatment results presented. The numerous illustrations and tables will serve to assist the reader in understanding the presented data
|